UK markets open in 53 minutes

Pharma Mar, S.A. (PHMMF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
31.15+4.30 (+16.01%)
At close: 12:16PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 609.96M
Enterprise value 482.38M
Trailing P/E 291.46
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.55
Price/book (mrq)2.98
Enterprise value/revenue 2.79
Enterprise value/EBITDA 150.46

Trading information

Stock price history

Beta (5Y monthly) -0.01
52-week change 3-2.24%
S&P500 52-week change 323.20%
52-week high 346.26
52-week low 326.85
50-day moving average 330.28
200-day moving average 335.20

Share statistics

Avg vol (3-month) 337
Avg vol (10-day) 310
Shares outstanding 517.47M
Implied shares outstanding 617.86M
Float 813.71M
% held by insiders 121.39%
% held by institutions 17.76%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.7
Forward annual dividend yield 41.98%
Trailing annual dividend rate 30.65
Trailing annual dividend yield 32.42%
5-year average dividend yield 4N/A
Payout ratio 4575.95%
Dividend date 3N/A
Ex-dividend date 412 Jun 2024
Last split factor 21:12
Last split date 322 Jul 2020

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.25%
Operating margin (ttm)-11.32%

Management effectiveness

Return on assets (ttm)-0.98%
Return on equity (ttm)0.99%

Income statement

Revenue (ttm)162.14M
Revenue per share (ttm)8.84
Quarterly revenue growth (yoy)11.70%
Gross profit (ttm)N/A
EBITDA -2.66M
Net income avi to common (ttm)2.03M
Diluted EPS (ttm)0.12
Quarterly earnings growth (yoy)63.00%

Balance sheet

Total cash (mrq)159.72M
Total cash per share (mrq)9.06
Total debt (mrq)40.26M
Total debt/equity (mrq)20.89%
Current ratio (mrq)2.62
Book value per share (mrq)10.97

Cash flow statement

Operating cash flow (ttm)-11.81M
Levered free cash flow (ttm)-23.19M